School of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada.
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02168-19.
is an opportunistic pathogen that is inherently resistant to many antibiotics and represents an increasing threat due to the emergence of drug-resistant strains. There is a pressing need to develop innovative antimicrobials against this pathogen. In this study, we identified the O-specific antigen (OSA) of serotype O6 as a novel target for therapeutic intervention. Binding of monoclonal antibodies and antigen-binding fragments therefrom to O6 OSA leads to rapid outer membrane destabilization and inhibition of cell growth. The antimicrobial effect correlated directly with antibody affinity. Antibody binding to the O antigen of a second lipopolysaccharide (LPS) type present in or to the LPS core did not affect cell viability. Atomic force microscopy showed that antibody binding to OSA resulted in early flagellum loss, formation of membrane blebs, and eventually complete outer membrane loss. We hypothesize that antibody binding to OSA disrupts a key interaction in the outer membrane.
是一种机会性病原体,对许多抗生素具有固有抗性,由于耐药菌株的出现,它构成的威胁日益增加。迫切需要针对这种病原体开发创新的抗菌药物。在这项研究中,我们确定了血清型 O6 的 O-特异性抗原 (OSA) 是治疗干预的新靶标。单克隆抗体及其抗原结合片段与 O6 OSA 的结合导致快速的外膜不稳定和细胞生长抑制。抗菌作用与抗体亲和力直接相关。抗体与 或存在的第二种脂多糖 (LPS) 型的 O 抗原结合,或与 LPS 核心结合,不会影响细胞活力。原子力显微镜显示,抗体与 OSA 的结合导致早期鞭毛丧失、膜泡形成,最终导致完整的外膜丧失。我们假设抗体与 OSA 的结合破坏了 外膜中的关键相互作用。